Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


1. Identify and present adverse events in an objective, non-judgmental, and educational manner with an aim to identify areas of systemic improvement.
2. Discuss difficult cases with the same aim of identifying systems errors.
3. Incorporate the learning points from the discussion to improve their practice in regards to patient safety.

Target Audience

The target audience for this activity is all neurology faculty and trainees.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Brent Silver, Speaker, has no relevant financial relationships to disclose.

Kwan Hon Vincent Lau, Course Director, has no relevant financial relationships to disclose.

Sakina Flint, Program Manager, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.